Sheena Hembrador

Sheena Hembrador

Auto-generated profile, based on publicly available information

Sheena Hembrador

Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2008 in Circulation
Verified
Journal Article
Closed access
PDF file
MNMatthias Nahrendorf
Matthias Nahrendorf
HZHanwen Zhang
Hanwen Zhang
SHSheena Hembrador
Sheena Hembrador
PPPeter Panizzi
Peter Panizzi
DSDavid E. Sosnovik
David E. Sosnovik
RWRalph Weissleder
Ralph Weissleder
Background— Macrophages participate centrally in atherosclerosis, and macrophage markers (eg, CD68, MAC-3) correlate well with lesion severity and therapeutic modulation. On the basis of the avidity of lesional macrophages for polysaccharide-containing supramolecular structures such as nanoparticles, we have developed a new positron emission tomography (PET) agent with optimized pharmacokinetics to allow in vivo imaging at tracer concentrations. Methods and Results— A dextranated and DTPA-modified magnetofluorescent 20-nm nanoparticle was labeled with the PET tracer 64 Cu (1 mCi/0.1 mg nanoparticles) to yield a PET, magnetic resonance, and optically detectable imaging agent. Peak PET activity 24 hours after intravenous injection into mice deficient in apolipoprotein E with experimental atherosclerosis mapped to areas of high plaque load identified by computed tomography such as the aortic root and arch and correlated with magnetic resonance and optical imaging. Accumulated dose in apolipoprotein E–deficient aortas determined by gamma counting was 260% and in carotids 392% of respective wild-type organs ( P <0.05 both). Autoradiography of aortas demonstrated uptake of the agent into macrophage-rich atheromata identified by Oil Red O staining of lipid deposits. The novel nanoagent accumulated predominantly in macrophages as determined by fluorescence microscopy and flow cytometry of cells dissociated from aortas. Conclusions— This report establishes the capability of a novel trimodality nanoparticle to directly detect macrophages in atherosclerotic plaques. Advantages include improved sensitivity; direct correlation of PET signal with an established biomarker (CD68); ability to readily quantify the PET signal, perform whole-body vascular surveys, and spatially localize and follow the trireporter by microscopy; and clinical translatability of the agent given similarities to magnetic resonance imaging probes in clinical trials.

1 October 2009 in JACC: Cardiovascular Imaging
Verified
Journal Article
Closed access
MNMatthias Nahrendorf
Matthias Nahrendorf
EKEdmund Keliher
Edmund Keliher
PPPeter Panizzi
Peter Panizzi
HZHanwen Zhang
Hanwen Zhang
SHSheena Hembrador
Sheena Hembrador
RWRalph Weissleder
Ralph Weissleder

1 April 2018 in Chest
Verified
Journal Article
Closed access
DJDavid R. Janz
David R. Janz
MSMatthew W. Semler
Matthew W. Semler
AJAaron M. Joffe
Aaron M. Joffe
JCJonathan D. Casey
Jonathan D. Casey
RLRobert J. Lentz
Robert J. Lentz
MGMatthew Griffith
Matthew Griffith

1 December 2011 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
BPBryan E. Pfingst
Bryan E. Pfingst
DCDeborah J. Colesa
Deborah J. Colesa
SHSheena Hembrador
Sheena Hembrador
SKStephen Y. Kang
Stephen Y. Kang
JMJohn C. Middlebrooks
John C. Middlebrooks
GSGina L. Su
Gina L. Su
Perception of electrical stimuli varies widely across users of cochlear implants and across stimulation sites in individual users. It is commonly assumed that the ability of subjects to detect and discriminate electrical signals is dependent, in part, on conditions in the implanted cochlea, but evidence supporting that hypothesis is sparse. The objective of this study was to define specific relationships between the survival of tissues near the implantedelectrodes and the functional responses to electrical stimulation of those electrodes.Psychophysical and neurophysiological procedures were used to assess stimulus detection as a function of pulse rate under the various degrees of cochlear pathology. Cochlear morphology, assessed post-mortem, ranged from near-normal numbers of hair cells, peripheral processes and spiral ganglion cells, to complete absence of hair cells and peripheral processes and small numbers of surviving spiral ganglion cells. The psychophysical and neurophysiological studies indicated that slopes and levels of the threshold versus pulse rate functions reflected multipulse integration throughout the 200 ms pulse train with an additional contribution of interactions between adjacent pulses at high pulse rates. The amount of multipulse integration was correlated with the health of the implanted cochlea with implications for perception of more complex prosthetic stimuli.

1 September 2016 in A&A Practice
Verified
Journal Article
Closed access
MHMargaret M. Hockett
Margaret M. Hockett
SHSheena Hembrador
Sheena Hembrador
ALAlex Lee
Alex Lee
A 69-year-old man with a history of chronic pain and opioid use presented for total hip arthroplasty. In the interests of ensuring early mobilization and pain control, we chose a continuous quadratus lumborum block technique, a novel ultrasound-guided block that has not yet been described for total hip arthroplasty, hypothesizing that it would be motor-sparing. While the perineural catheter was infused, the patient required no IV opioids. He was able to ambulate on the first postoperative day, reporting pain scores between 0 and 3/10. The quadratus lumborum block is a promising technique that, in our patient, was motor-sparing and provided excellent pain control.

1 May 2010 in Health Physics
Verified
Journal Article
Open access
WOWerner Olipitz
Werner Olipitz
SHSheena Hembrador
Sheena Hembrador
MDMatthew Davidson
Matthew Davidson
JYJacquelyn C. Yanch
Jacquelyn C. Yanch
BEBevin P. Engelward
Bevin P. Engelward
Radiation exposure of humans generally results in low doses delivered at low dose rate. Our limited knowledge of the biological effects of low dose radiation is mainly based on data from the atomic bomb Life Span Study (LSS) cohort. However, the total doses and dose rates in the LSS cohort are still higher than most environmental and occupational exposures in humans. Importantly, the dose rate is a critical determinant of health risks stemming from radiation exposure. Understanding the shape of the dose-rate response curve for different biological outcomes is thus crucial for projecting the biological hazard from radiation in different environmental and man-made conditions. A significant barrier to performing low dose-rate studies is the difficulty in creating radiation source configurations compatible with long-term cellular or animal experiments. In this study the design and characterization of a large area, 125I-based irradiator is described. The irradiator allows continuous long-term exposure of mice at variable dose rates and can be sited in standard animal care facilities. The dose rate is determined by the level of 125I activity added to a large NaOH-filled rectangular phantom. The desired dose rate is maintained at essentially constant levels by weekly additions of 125I to compensate for decay. Dosimetry results for long-term animal irradiation at targeted dose rates of 0.00021 and 0.0021 cGy min−1 are presented.